CJC-1295 and Ipamorelin are synthetic peptides commonly utilized in laboratory research settings to study growth hormone–related signaling pathways and endocrine system function.
CJC-1295 is a growth hormone–releasing hormone (GHRH) analog designed to interact with GHRH receptors in experimental models.
Ipamorelin is a selective growth hormone secretagogue that acts on ghrelin (GHS-R1a) receptors and is studied for its receptor-specific activity in research environments.
When combined, this peptide blend is used in preclinical and laboratory investigations examining:
-
Growth hormone signaling mechanisms
-
Pulsatile hormone release patterns
-
Receptor selectivity and binding dynamics
-
Endocrine system pathway interactions
-
Cellular and molecular responses in controlled settings